Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
Columbus Regional Health Electrophysiology team completes 500th ablation case for treating irregular heartbeats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback